Multi-epitopic peptide compounds and vaccines against leishmaniasis
US11559575B2 · kind B2 · utility
0Cited by
1References
22Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 29, 2019 |
| Grant date | Jan 24, 2023 |
| Priority date | — |
| Expiry date | May 29, 2039 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to multi-epitopic peptide compounds obtained from PSA, HwB and LmLRAB proteins of Leishmania as well as to pharmaceutical compositions and vaccines for use against one or more leishmaniases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.